pancreatic cancer

Patient-Derived Organoids for Chronic Pancreatitis Therapy

by

Researchers at the Salk Institute have developed a patient-derived organoid platform to study chronic pancreatitis, a condition affecting approximately three million people worldwide for which no cure currently exists. By generating 37 organoids from patients, the study—published in Cell Stem Cell—identified cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction as a key therapeutic target and uncovered … Read more

New Compound Shows Promise for Pancreatic Cancer Treatment

by

Researchers have identified a new chemical compound, DE19725241, that shows potential in targeting the fat mass and obesity-associated protein (FTO) to treat pancreatic cancer. According to a study published in BIO Integration, the compound demonstrated selective antiproliferative activity in pancreatic cancer cell lines by binding to specific protein sites, offering a potential new scaffold for … Read more

Targeted Therapy Doubles Survival in Rare Bile Duct Cancer

by

The U.S. Food and Drug Administration approved zenocutuzumab as a second-line therapy for NRG1-positive cholangiocarcinoma on May 8. According to results from the eNRGy phase 2 clinical trial published in the Journal of Clinical Oncology, the drug more than doubled the median progression-free survival to 9.2 months, compared to the approximately four months typically seen … Read more

New Cellular Triggers for Precancerous Pancreas Lesions Discovered

by

A New Understanding of Pancreatic Cancer: Why Precursor Lesions Don’t Always Become Malignant For years, researchers operated under a clear assumption: as precancerous cells in the pancreas evolved, they would inevitably command their surrounding environment to support their growth. A groundbreaking study published in Cancer Discovery has now shattered that paradigm, revealing that the transition … Read more

Cancer-driving MYC protein also helps tumors repair damaged DNA

by

Breaking the Shield: How Targeting MYC’s DNA Repair Secret Could Revolutionize Cancer Treatment For decades, the medical community has viewed the MYC protein as a relentless engine of cancer growth. It is one of the most studied oncogenes because it is overactive in the vast majority of human cancers, acting as a master switch that … Read more

Man, 43, Went to the Doctor for a Stomach Bug. 6 Months Later, He Was Dead from the ‘Silent Killer’

by

Breaking the Silence: The Future of Pancreatic Cancer Detection For too long, pancreatic cancer has been branded the silent killer. As seen in the tragic case of Michael Armishaw, a 43-year-old from Nottinghamshire, symptoms often emerge only after the disease has reached an advanced stage. In Michael’s case, initial stomach pain was mistaken for a … Read more

Former Sen. Ben Sasse, dying of cancer, reflects on family, faith and the future of America

by

Former U.S. Senator from Nebraska Ben Sasse, 54, is battling terminal pancreatic cancer. Despite a grim initial prognosis, a modern clinical trial drug is providing him with extended time to voice his concerns regarding the state of American politics and the future of the country. A Medical Breakthrough and a Terminal Diagnosis Sasse was given … Read more

POLAR Trial: Genomic and Immunologic Biomarkers in Metastatic Pancreatic Cancer

by

Precision Medicine Gains Momentum in Pancreatic and Biliary Tract Cancers: A New Era of Targeted Therapies The landscape of treatment for pancreatic and biliary tract cancers is undergoing a significant shift, moving away from broad-spectrum approaches towards highly personalized strategies. Recent clinical trials, like the POLAR and related studies, are demonstrating the potential of combining … Read more

Vegetarian diet linked to lower risk for five cancers, but higher for one

by

Vegetarian Diets and Cancer Risk: A New Look at the Evidence A groundbreaking new study, analyzing data from over 1.8 million individuals, reveals a complex relationship between vegetarian diets and cancer risk. While vegetarians demonstrate a lower risk for several cancers, the findings aren’t uniform, and surprisingly, a higher risk was observed for one specific … Read more

Study reveals pancreatic cancer’s early immune evasion tactics

by

Pancreatic Cancer’s Hidden Start: How Early Detection is Shifting the Paradigm For years, pancreatic cancer has been notoriously difficult to treat, largely due to late diagnosis. But a groundbreaking new study from the Hebrew University of Jerusalem is changing our understanding of how this deadly disease begins, suggesting it may start preparing to evade the … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]